导向失脂症治疗:一个人口的药理动力学和药理动力学框架为obicetrapibib治疗
Allison Dunn1, Marc Ditmarsch2, John J P Kastelein2,3
1Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, MD, USA.
Journal of clinical pharmacology
|May 9, 2024
概括
奥比塞特拉皮有效地修改了失脂症的脂质谱,显示出对LDL-C和HDL-C水平的显著影响. 这种药理动力学和药理动力学分析支持其作为新型治疗剂的发展.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药理学 临床药理学
- 药物开发 药物开发
背景情况:
- 奥比塞特拉皮布是一种研究中的胆固醇转移蛋白抑制剂.
- 它目前正在第三阶段的临床试验中,用于失脂症的辅助治疗.
研究的目的:
- 为了描述obicetrapib的药理动力学 (PK) 和药理动力学 (PD) 配置.
- 开发一个人口PK模型,并为PK/PD周转率模型提供信息.
主要方法:
- 分析了7项临床试验中的健康成年人和失脂症患者的数据.
- 开发一个具有对人体重量进行全度量缩放的3个隔间PK模型.
- 顺序建模来描述对LDL-C和HDL-C的影响.
主要成果:
- 一个具有全度尺度缩放的3个隔间模型最好地描述了obicetrapib PK.
- 典型清除:0.81 L/h;中央分布体积:一个75公斤患者的36.1L.
- 预测的最大变化:51.1%的LDL-C降低和224%的HDL-C增加.
结论:
- 开发的PK/PD模型准确地描述了obicetrapib的处置和作用.
- 该模型证明了内部的一致性,并支持obicetrapib的临床开发.
- 这些发现支持obicetrapib作为治疗失脂症的治疗潜力.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
652
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
652
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38
Pharmacokinetics: Overview
6.3K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
6.3K
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Pharmacodynamics: Overview and Principles
1.1K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.1K


